UK decision to mix Covid-19 vaccines raises concern
People are concerned over Britain's decision to allow people to be given shots of different Covid-19 vaccines despite a lack of evidence about the extent of immunity offered by mixing doses.
Britain will allow people to be given shots of different Covid-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.
In a departure from other strategies globally, the government said people could be given a mix-and-match of two Covid-19 shots, for example if the same vaccine dose was out of stock, according to guidelines published on New Year's Eve.
"If the same vaccine is not available, or if the first product received is unknown, it is reasonable to offer one dose of the locally available product to complete the schedule," according to the guidelines.
Mary Ramsay, head of immunisations at Public Health England, said this would only happen on extremely rare occasions, and that the government was not recommending the mixing of vaccines, which require at least two doses given several weeks apart.
"Every effort should be made to give them the same vaccine, but where this is not possible it is better to give a second dose of another vaccine than not at all," she said.
READ MORE: Britain prepares to rollout Pfizer/BioNTech Covid-19 vaccine
There's a reason clinical trials happen the way they do. Mixing and matching vaccines when they haven't been tested under those conditions, as you say, isn't a good idea. Scientists can use their extensive knowledge to determine how they may react but w/out testing we can't know
— Kirsty Baillie (@kirstybaillie) January 2, 2021
Second-highest toll in Europe
Covid-19 has killed more 74,000 people in Britain, making it the second-highest death toll in Europe, and health officials are racing to deliver doses to help end the pandemic as fears grow that the weak health service could be overwhelmed.
Earlier this week, the government reactivated emergency hospitals built at the start of the outbreak as wards fill up with Covid-19 patients.
Britain has been at the forefront of approving the new coronavirus vaccines, becoming the first country to give emergency authorisation to the Pfizer/BioNTech and the AstraZeneca/University of Oxford vaccines last month.
Both vaccines are meant to be administered as two shots, given several weeks apart, but they were not designed to be mixed together.
The government's new guidelines said there "is no evidence on the interchangeability of the Covid-19 vaccines although studies are underway".
READ MORE: Vaccines boost Big Pharma’s image, but won’t change its ways
However, the advice said that while every effort should be made to complete the dosing regimen with the same vaccine, if the patient is at "immediate high risk" or is considered "unlikely to attend again" they can be given different vaccines.
Britain sparked controversy earlier this week by announcing plans to delay giving the coronavirus vaccine booster shot in an attempt to ensure more people could be given the more limited protection conferred by a single dose.
The top US infectious diseases expert, Anthony Fauci, said on Friday he did not agree with the British approach of delaying the second dose up to 12 weeks.
"I would not be in favour of that," he told CNN. "We're going to keep doing what we're doing."
READ MORE: UK hospitals scramble to make space for patients as Covid-19 cases soar